Does Mirabegron Have a Positive Impact on Sexual Function in Females With Overactive Bladder

Kasr El Aini Hospital80 enrolled

Overview

80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms

Study Type

OBSERVATIONAL

Enrollment

Conditions

Females With Overactive Bladder Symptoms, Urgency & Urge Incontinence

Interventions

Follow up of female sexual functionDRUG

Mirabegron 50mg once daily for treatment of overactive bladder symptoms

Eligibility

Sex: FEMALEHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * any female with overactive bladder symptoms, urgency and urgency incontinence Exclusion Criteria: * neurologic abnormalities * Weak bladder contractility * Diabetics

Outcomes

Primary Outcomes

Sexual function evaluation after 6 months

Sexual function evaluation using female sexual function index FSFI

Time frame: 6 months

Central Contacts

Samer Morsy

CONTACT

01000908851 Samermorsy1@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.